Dengue vaccine: Opportunities and challenges

IDrugs

Volumn 11, Issue 1, 2008, Pages 42-45

  Hatch, S ^a   Mathew, A ^a   Rothman, A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Dengue fever; Hemorrhagic fever; Immunology; T cells; Vaccines

Indexed keywords

CHIMERIVAX JE; DENGUE VACCINE; UNCLASSIFIED DRUG;

DENGUE; DENGUE VIRUS; HUMAN; IMMUNOPATHOGENESIS; INFECTION PREVENTION; MORTALITY; RESEARCH PRIORITY; REVIEW; T LYMPHOCYTE; TROPICS; VIRUS PATHOGENESIS;

ANIMALS; CLINICAL TRIALS AS TOPIC; DENGUE; DENGUE VACCINES; DENGUE VIRUS; DISEASE MODELS, ANIMAL; HUMANS; TECHNOLOGY, PHARMACEUTICAL;

EID: 37849009132     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)